Diadem
Brescia
About Diadem
Diadem is an innovative blood-based test exploiting a proprietary antibody targeting a specific conformation of p53 protein.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $21.6M
- Last round: Grant (Sep 2022)
- Website: diademdx.com
Industries & Categories
Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/diadem-101883 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.